STOCK TITAN

Communiqué from Boliden's Extraordinary General Meeting

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

At Boliden's Extraordinary General Meeting held on January 23, 2025, in Stockholm, shareholders approved a significant resolution authorizing the Board of Directors to issue new shares. The authorization allows for multiple share issues until the Annual General Meeting 2025, with or without preferential rights for existing shareholders.

If executed without preferential rights, the new share issuance is capped at 15 percent of the total shares outstanding as of the Extraordinary General Meeting date. The primary purpose of this share issuance is to optimize capital structure and refinance approximately half of the bridge loan used to acquire Neves-Corvo and Zinkgruvan operations.

All'Assemblea Generale Straordinaria di Boliden tenutasi il 23 gennaio 2025 a Stoccolma, gli azionisti hanno approvato una significativa delibera che autorizza il Consiglio di Amministrazione a emettere nuove azioni. L'autorizzazione consente emissioni di azioni multiple fino all'Assemblea Generale Annuale 2025, con o senza diritti di preferenza per gli azionisti esistenti.

Se eseguita senza diritti di preferenza, l'emissione di nuove azioni è limitata a 15 percento del totale delle azioni in circolazione alla data dell'Assemblea Generale Straordinaria. Lo scopo principale di questa emissione di azioni è ottimizzare la struttura del capitale e rifinanziare circa la metà del prestito ponte utilizzato per acquisire le operazioni di Neves-Corvo e Zinkgruvan.

En la Junta General Extraordinaria de Boliden celebrada el 23 de enero de 2025 en Estocolmo, los accionistas aprobaron una resolución significativa que autoriza a la Junta Directiva a emitir nuevas acciones. La autorización permite múltiples emisiones de acciones hasta la Junta General Anual de 2025, con o sin derechos de preferencia para los accionistas existentes.

Si se ejecuta sin derechos de preferencia, la emisión de nuevas acciones está limitada a el 15 por ciento del total de acciones en circulación a la fecha de la Junta General Extraordinaria. El propósito principal de esta emisión de acciones es optimizar la estructura de capital y refinanciar aproximadamente la mitad del préstamo puente utilizado para adquirir las operaciones de Neves-Corvo y Zinkgruvan.

2025년 1월 23일 스톡홀름에서 열린 볼리든의 특별주주총회에서 주주들은 이사회에 새 주식을 발행할 수 있는 중대한 결의안을 승인했습니다. 이번 승인은 2025년 정기주주총회까지 다수의 주식 발행을 허용합니다, 기존 주주를 위한 우선권이 있을 수도 있고 없을 수도 있습니다.

우선권 없이 실행될 경우, 새로운 주식 발행은 특별주주총회 날짜 기준 총 주식의 15%로 제한됩니다. 이번 주식 발행의 주요 목적은 자본 구조를 최적화하고 Neves-Corvo 및 Zinkgruvan 운영을 인수하는 데 사용된 브리지 대출의 약 절반을 재융자하는 것입니다.

Lors de l'Assemblée Générale Extraordinaire de Boliden qui s'est tenue le 23 janvier 2025 à Stockholm, les actionnaires ont approuvé une résolution significative autorisant le Conseil d'Administration à émettre de nouvelles actions. Cette autorisation permet plusieurs émissions d'actions jusqu'à l'Assemblée Générale Annuelle de 2025, avec ou sans droits préférentiels pour les actionnaires existants.

Si elle est exécutée sans droits préférentiels, l'émission de nouvelles actions est limitée à 15 % du total des actions en circulation à la date de l'Assemblée Générale Extraordinaire. L'objectif principal de cette émission d'actions est d'optimiser la structure du capital et de refinancer environ la moitié du prêt relais utilisé pour acquérir les opérations de Neves-Corvo et Zinkgruvan.

Auf der außerordentlichen Hauptversammlung von Boliden, die am 23. Januar 2025 in Stockholm stattfand, genehmigten die Aktionäre einen bedeutenden Beschluss, der den Vorstand ermächtigt, neue Aktien auszugeben. Die Ermächtigung ermöglicht mehrere Aktienausgaben bis zur Hauptversammlung 2025, mit oder ohne Vorzugsrechte für bestehende Aktionäre.

Wird die Ausgabe ohne Vorzugsrechte durchgeführt, ist die Ausgabe neuer Aktien auf 15 Prozent der insgesamt ausstehenden Aktien am Tag der außerordentlichen Hauptversammlung begrenzt. Das Hauptziel dieser Aktienausgabe ist die Optimierung der Kapitalstruktur und die Refinanzierung von etwa der Hälfte des Brücken kredits, der zur Akquisition der Betriebe Neves-Corvo und Zinkgruvan verwendet wurde.

Positive
  • Flexibility in capital raising through multiple potential share issuances
  • Clear cap of 15% on share issuance without preferential rights
  • Strategic refinancing of acquisition-related bridge loan
Negative
  • Potential shareholder dilution up to 15% if issued without preferential rights
  • Additional debt burden from bridge loan requiring refinancing

Boliden's Extraordinary General Meeting was held on January 23, 2025 live in Stockholm and through postal voting.

STOCKHOLM, Jan. 23, 2025 /PRNewswire/ --

Resolution on authorization for the Board of Directors to resolve on new share issues

The Meeting resolved, in accordance with the Board of Directors' proposal, to authorize the Board of Directors to, on one or more occasions during the period up to the Annual General Meeting 2025, resolve on a new issue of shares with or without preferential rights for the company's shareholders. If a share issue is carried out without preferential rights for the company's shareholders, the total number of shares that may be issued may not exceed the number of shares which corresponds to 15 percent of the number of shares as of the date of the Extraordinary General Meeting. The purpose of a share issue shall be to raise proceeds to achieve an efficient capital structure and refinance approximately half of the bridge loan secured to finance the acquisition of Neves-Corvo and Zinkgruvan.

Minutes

The minutes with complete resolutions from the Meeting will be available on the company's website at https://www.boliden.com under "Operations/Corporate Governance/Annual General Meetings". A copy of the minutes, except for the voting list, will also be sent to shareholders who request it from the company and who provide their postal address.

For further information, please contact:

Klas Nilsson
Director Group Communications
+46 70 453 6588
klas.nilsson@boliden.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/boliden/r/communique-from-boliden-s-extraordinary-general-meeting,c4094974

The following files are available for download:

https://mb.cision.com/Main/997/4094974/3221144.pdf

Press release

Cision View original content:https://www.prnewswire.com/news-releases/communique-from-bolidens-extraordinary-general-meeting-302358686.html

SOURCE Boliden

FAQ

What was the main resolution passed at Boliden's January 2025 Extraordinary General Meeting?

The meeting approved authorization for the Board of Directors to issue new shares, with or without preferential rights, until the Annual General Meeting 2025.

What is the maximum dilution possible from Boliden's new share issuance authorization?

If issued without preferential rights, the maximum dilution is capped at 15% of the total shares outstanding as of the January 23, 2025 Extraordinary General Meeting.

What is the purpose of Boliden's planned share issuance?

The share issuance aims to optimize capital structure and refinance approximately half of the bridge loan used to acquire Neves-Corvo and Zinkgruvan operations.

How long is Boliden's Board authorized to issue new shares?

The Board is authorized to issue new shares on one or more occasions from January 23, 2025, until the Annual General Meeting 2025.

BOLIDEN AB UNSP/ADR

OTC:BDNNY

BDNNY Rankings

BDNNY Latest News

BDNNY Stock Data

7.77B
136.74M
0%
Other Industrial Metals & Mining
Basic Materials
Link
United States of America
Stockholm